Rejko Krueger

577 total citations
19 papers, 248 citations indexed

About

Rejko Krueger is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Rejko Krueger has authored 19 papers receiving a total of 248 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Neurology, 7 papers in Molecular Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Rejko Krueger's work include Parkinson's Disease Mechanisms and Treatments (10 papers), Neurological disorders and treatments (5 papers) and Lysosomal Storage Disorders Research (2 papers). Rejko Krueger is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (10 papers), Neurological disorders and treatments (5 papers) and Lysosomal Storage Disorders Research (2 papers). Rejko Krueger collaborates with scholars based in Luxembourg, Germany and United States. Rejko Krueger's co-authors include Jens C. Schwamborn, Nicolas Casadei, Olaf Rieß, Stefan Helling, Paul Antony, Takaomi C. Saido, Philipp J. Kahle, Silke Nuber, Ronald Melki and Laura Pieri and has published in prestigious journals such as Brain, Neurology and Scientific Reports.

In The Last Decade

Rejko Krueger

16 papers receiving 246 citations

Peers

Countries citing papers authored by Rejko Krueger

Since Specialization

Citations

This map shows the geographic impact of Rejko Krueger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rejko Krueger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rejko Krueger more than expected).

Fields of papers citing papers by Rejko Krueger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rejko Krueger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rejko Krueger. The network helps show where Rejko Krueger may publish in the future.

Co-authorship network of co-authors of Rejko Krueger

This figure shows the co-authorship network connecting the top 25 collaborators of Rejko Krueger. A scholar is included among the top collaborators of Rejko Krueger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rejko Krueger. Rejko Krueger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	VPS35 mutation inhibits PINK1/parkin-mediated mitophagy via increased LRRK2 kinase activity 2025 ·Brain ·(unknown), (unknown), (unknown), Bjørn Holst, Rejko Krueger, Wim Vandenberghe	0
2	MIRO1 mutation leads to metabolic maladaptation resulting in Parkinson’s disease-associated dopaminergic neuron loss 2025 ·npj Systems Biology and Applications ·Alise Žagare, Thomas Sauter, (unknown), Maria Pires Pacheco, Rejko Krueger, Jens C. Schwamborn, Cláudia Saraiva	0
3	Parkinson’s disease mutant Miro1 causes mitochondrial dysfunction and dopaminergic neuron loss 2025 ·Brain ·(unknown), (unknown), (unknown), (unknown), Alise Žagare, Pierre Garcia, (unknown), (unknown), Jochen Ohnmacht, (unknown), (unknown), (unknown), Alessandro Michelucci, Anne‐Marie Marzesco, Manuel Buttini, Thorsten Schmidt, Anne Grünewald, Jens C. Schwamborn, Rejko Krueger, Cláudia Saraiva	5
4	Sex-specific progression of Parkinson's disease: A longitudinal mixed-models analysis 2025 ·Journal of Parkinson s Disease ·Anne-Marie Hanff, Christopher McCrum, Armin Rauschenberger, Gloria Aguayo, Claire Pauly, (unknown), (unknown), Maurice P. Zeegers, Anja Leist, Rejko Krueger	2
5	Interpretable Machine Learning for Cross‐Cohort Prediction of Motor Fluctuations in Parkinson's Disease 2025 ·Movement Disorders ·(unknown), Lukas Pavelka, Graziella Mangone, (unknown), Marie Vidailhet, Jean‐Christophe Corvol, Rejko Krueger, Enrico Glaab	1
6	Insulin resistance compromises midbrain organoid neuronal activity and metabolic efficiency predisposing to Parkinson’s disease pathology 2025 ·Journal of Tissue Engineering ·Alise Žagare, (unknown), (unknown), (unknown), (unknown), (unknown), Gemma Gomez‐Giro, Christian Jäger, Paul Antony, Rashi Halder, Rejko Krueger, Enrico Glaab, Egils Stalidzāns, Giuseppe Arena, Jens C. Schwamborn	6
7	The role of alpha-synuclein in synucleinopathy: Impact on lipid regulation at mitochondria–ER membranes 2025 ·npj Parkinson s Disease ·Peter A. Barbuti, Cristina Guardia‐Laguarta, (unknown), Zena K. Chatila, Xena Flowers, (unknown), (unknown), (unknown), (unknown), Nobutaka Hattori, Elizabeth M. Bradshaw, Ulf Dettmer, Saranna Fanning, Vilas Menon, Hasini Reddy, Andrew F. Teich, Rejko Krueger, Estela Área-Gómez, Serge Przedborski	6
8	Park7 deletion leads to sex-specific transcriptome changes involving NRF2-CYP1B1 axis in mouse midbrain astrocytes 2025 ·npj Parkinson s Disease ·(unknown), Tony Heurtaux, (unknown), (unknown), Jochen Ohnmacht, (unknown), Ibrahim Boussaad, Rashi Halder, Pierre Garcia, Rejko Krueger, Michel Mittelbronn, Manuel Buttini, Thomas Sauter, Lasse Sinkkonen	4
9	Lessons learned from the COVID-19 pandemic: identifying hesitant groups and exploring reasons for vaccination hesitancy, from adolescence to late adulthood 2024 ·Frontiers in Public Health ·(unknown), (unknown), (unknown), (unknown), Soumyabrata Ghosh, (unknown), Joëlle V. Fritz, Michel Vaillant, (unknown), Robin Samuel, Venkata Satagopam, Rejko Krueger, Anja Leist, (unknown)	0
10	Iron-sulfur cluster loss in mitochondrial CISD1 mediates PINK1 loss-of-function phenotypes 2024 ·eLife ·(unknown), (unknown), Christopher R. Weber, (unknown), (unknown), Patrick Ziegler, Thomas Schettgen, (unknown), Vivek Venkataramani, Bernhard Michalke, Eva-Maria Hanschmann, Giuseppe Arena, Rejko Krueger, (unknown), Axel Methner	4
11	Multifactorial assessment of Parkinson’s disease course and outcomes using trajectory modeling in a multiethnic, multisite cohort – extension of the LONG-PD study 2023 ·Frontiers in Aging Neuroscience ·Bruce A. Chase, Rejko Krueger, Lukas Pavelka, Sun Ju Chung, Jan Aasly, Efthimios Dardiotis, (unknown), (unknown), (unknown), (unknown), Roberta Frigerio, Demetrius M. Maraganore, Katerina Markopoulou	6
12	Unraveling Molecular Mechanisms of THAP1 Missense Mutations in DYT6 Dystonia 2020 ·Journal of Molecular Neuroscience ·Fubo Cheng, Michael Walter, Zinah Wassouf, Thomas Hentrich, Nicolas Casadei, Julia M. Schulze‐Hentrich, Peter A. Barbuti, Rejko Krueger, Olaf Rieß, (unknown), Thomas Ott	14
13	Machine learning-assisted neurotoxicity prediction in human midbrain organoids 2020 ·Parkinsonism & Related Disorders ·Anna S. Monzel, Kathrin Hemmer, Tony Kaoma, Lisa M. Smits, Silvia Bolognin, Philippe Lucarelli, Isabel Rosety, Alise Žagare, Paul Antony, Sarah Nickels, Rejko Krueger, Francisco Azuaje, Jens C. Schwamborn	55
14	Contributing Factors and Evolution of Impulse Control Disorder in the Luxembourg Parkinson Cohort 2020 ·Frontiers in Neurology ·(unknown), Claire Pauly, Michel Vaillant, Géraldine Hipp, Manon Gantenbein, Rejko Krueger, Nico J. Diederich	3
15	Automated high-throughput high-content autophagy and mitophagy analysis platform 2019 ·Scientific Reports ·Jonathan Arias, Javier Jarazo, Jonas Walter, Gemma Gomez‐Giro, (unknown), Rejko Krueger, Paul Antony, Jens C. Schwamborn	13
16	Overexpression of the calpain-specific inhibitor calpastatin reduces human alpha-Synuclein processing, aggregation and synaptic impairment in [A30P]αSyn transgenic mice 2014 ·Human Molecular Genetics ·(unknown), Nicolas Casadei, (unknown), Takaomi C. Saido, Jiro Takano, Philipp J. Kahle, Ralph A. Nixon, Mala V. Rao, Ronald Melki, Laura Pieri, Stefan Helling, Katrin Marcus, Rejko Krueger, Eliezer Masliah, Olaf Rieß, Silke Nuber	89
17	Comparison of beamformers for EEG source signal reconstruction 2014 ·Biomedical Signal Processing and Control ·(unknown), Govinda Poudel, Carrie Innes, Daniel Weiß, Rejko Krueger, Richard D. Jones	28
18	Long-Term Safety and Maintenance of Efficacy From an Open-Label Extension of the Double-Blind Pivotal Study of Levodopa-Carbidopa Intestinal Gel (LCIG) in Advanced Parkinson’s Disease Patients (P7.081) 2014 ·Neurology ·Hubert H. Fernandez, Rejko Krueger, John T. Slevin, Coleen Hall, Susan Eaton, Jordan Dubow, Krai Chatamra, Janet Benesh	1
19	Mutation analysis of the seven in absentia homolog 1 (SIAH1) gene in Parkinson’s disease 2006 ·Journal of Neural Transmission ·(unknown), Rejko Krueger, Dirk Woitalla, Thomas Müller, Simone Engelender, (unknown)	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact